statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What the Options Market Tells Us About Abbott Laboratories

Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee PR Newswire ABBOTT...

Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee

Behind the Scenes of Abbott Laboratories's Latest Options Trends

We also love that EPS results on Tuesday came in above the range management had forecasted...

Abbott Labs' surprise guidance bump is a major positive for its shareholders

Jamie Kelter Davis / Bloomberg via Getty Images

 Key TakeawaysAbbott Laboratories stock fell in intraday trading Wednesday as investors reacted to a first-quarter earnings report that beat...

Abbott Labs Stock Falls as Q2 Guidance Outweighs Earnings Beat

Nearly 14,000 heart pumps tied to hundreds of injuries and more than a dozen deaths are being recalled, according to federal health officials. The HeartMate II and HeartMate 3 Left Ventricular Assist...

Heart pumps tied to 14 deaths, hundreds of injuries are being recalled

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ...

Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings

Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance...

Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance

Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges PR Newswire...

Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
read more...

Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Volume	452.00
52-Wk High	$121.64
52-Wk Low	$89.67

Period	Estimated	Reported	Surprise	Result
Q2'24	$1.11	--	--	N/A
Q1'24	$0.95	$0.98	2.62%	BEAT
Q4'23	$1.19	$1.19	0.04%	BEAT
Q3'23	$1.10	$1.14	3.57%	BEAT
Q2'23	$1.05	$1.08	2.89%	BEAT

ABT Abbott Laboratories

About

Feed

News

Sentiment

Earnings

Fundamentals